Dr. Lasky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Breakthrough Way
Las Vegas, NV 89135Phone+1 702-732-1493Fax+1 702-732-1080- Is this information wrong?
Summary
- Dr. Joseph Lasky is a pediatric hematologist/oncologist in Las Vegas, NV. He received his medical degree from University of Illinois College of Medicine and has been in practice 17 years. He is experienced in sickle-cell anemia, pediatric sarcomas, leukemia, pediatric bone marrow transplantation, and pediatric hematopoietic stem cell transplantation.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 2003 - 2006
- University of ChicagoResidency, Pediatrics, 2000 - 2003
- University of Illinois College of MedicineClass of 2000
Certifications & Licensure
- NV State Medical License 2017 - 2025
- CA State Medical License 2003 - 2024
- IL State Medical License 2000 - 2003
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma Start of enrollment: 2005 Jan 01
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
- Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
- Join now to see all
Publications & Presentations
PubMed
- Case Report: Blinatumomab as upfront consolidation and maintenance therapy in a pediatric patient with high-risk B-cell acute lymphoblastic leukemia.Jessica Casey, Gupta, S., Lasky, J.> ;Frontiers in Oncology. 2023 Jan 1
- Pediatric Patients With Sickle Cell Disease at a Public Hospital: Nutrition, Compliance and Early Experience With L-Glutamine Therapy.Moran Gotesman, Guy Elgar, Laura Hernandez Santiago, Abigail Alvarez, Youngju Pak, Henry J Lin, Joseph L Lasky, Eduard H Panosyan> ;In Vivo. 2022 Jun 23
- 20 citationsEffect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.James F. Casella, Bruce A. Barton, Julie Kanter, L. Vandy Black, Suvankar Majumdar, Adlette Inati, Yasser Wali, Richard A. Drachtman, Miguel R. Abboud, Yurdanur Kilinç...> ;JAMA. 2021 Apr 20
- Join now to see all
Journal Articles
- A Phase 3 Trial of L-glutamine in Sickle Cell DiseaseRita Bellevue, Joseph L Lasky, Elliott P Vichinsky, Lewis L Hsu, Sharada Sarnaik, Lynne D Neumayr, Yutaka Niihara, Sophie Lanzkron, Ifeyinwa Osunkwo, Lance Sieger, Edu..., The New England Journal of Medicine
Press Mentions
- Introducing Vegas Inc’s 2021 Top DoctorsAugust 26th, 2021
Hospital Affiliations
- Harbor-UCLA Medical CenterTorrance, California
- Sunrise Hospital and Medical CenterLas Vegas, Nevada
- Summerlin Hospital Medical CenterLas Vegas, Nevada
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: